Synthesis and characterization of gadolinium and gold-doped layered double hydroxide and graphene oxide nanocomposites for therapeutic agent delivery
Multimodal delivery system (MDS) or theranostic delivery system (TDS) is still at its infancy. In this work, the concept of MDS was employed, where magnesium/zinc aluminium-layered double hydroxides (Zn/Mg-Al LDH) and graphene oxide (GO) were used as nanocarriers (host) to intercalate and ad...
Saved in:
| Main Author: | |
|---|---|
| Format: | Thesis |
| Language: | English |
| Published: |
2018
|
| Subjects: | |
| Online Access: | http://psasir.upm.edu.my/id/eprint/76907/1/ITMA%202018%2016%20-%20IR.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Multimodal delivery system (MDS) or theranostic delivery system (TDS) is still
at its infancy. In this work, the concept of MDS was employed, where
magnesium/zinc aluminium-layered double hydroxides (Zn/Mg-Al LDH) and
graphene oxide (GO) were used as nanocarriers (host) to intercalate and
adsorb therapeutic agents (chlorogenic acid, prochatetuic acid and gallic acid),
and contrast agents; gadolinium (Gd) as well as gold nanoparticles (AuNPs)
as guest molecules. The Gd contrast agent was used as the main contrast
agent for magnetic resonance imaging (MRI) and the AuNPs served as
supporting contrast agent.
The therapeutic and contrast agents were used to develop various the LDH
and GO-based nanocomposites. The agents were developed based on ion
exchange interaction in the LDH and non-covalent π-π stacking bonding and
OH/COOH hydrogen bonding in the GO. The synthesis routes adopted were
the Hummer’s modified method for GO and co-precipitation for LDH. The
mechanism and physico-chemical properties of the nanocomposite formation
were studied via characterization processes, such as transmission electron
microscopy (TEM) and field emission scanning electron microscopy (FESEM),
which were used for shape, size and morphological studies. Fourier
transformed-infrared spectroscopy (FTIR) and Raman spectroscopy were
used for chemical interaction studies. Inductive coupled plasma emission
spectroscopy (ICP‒ES), carbon, hydrogen, nitrogen and sulphur analysis
(CHNS) and energy-dispersive X-ray (EDS) were used to study the
composition as well as purity of the samples. The crystallinity and phase
change was studied with X-ray diffraction (XRD) and the ultra violet – visible
spectroscopy (UV-Vis) was used for drug release study. The anticancer efficacies of the nanocomposites and the pure phases were evaluated using
human liver cancer cell lines (HepG2) and mouse fibroblast cell lines (3T3)
were used in cytotoxicity studies. The inherent signal optimization was done
on a 3 Tesla MRI machine, to determine the diagnostic properties of the
nanocomposites.
Subsequent amounts of the loaded therapeutic agents were estimated
between 15-60%, depending on the nanocarrier and the therapeutic agent. All
the pharmacokinetic releases of the therapeutic agents were best fitted to the
pseudo-second order kinetic model. The XRD analysis results confirmed the
drug intercalation in the LDH galleries and adsorption on the GO surface.
Similarly, the FTIR and Raman spectroscopy confirmed the bonding that
occurred between the host and guest molecules. CHNS, ICP‒ES and EDX
equally showed the presence of all the intended compounds and elements in
the nanocomposites. The AuNPs grown on the LDH and GO nanocomposites
as observed from TEM and FESEM micrographs were poly-dispersed with
various shapes and sizes (2-120 nm).
The nanocomposites were observed to inhibit growth of HepG2 cells and
showed less toxic in the 3T3 cell lines. Preliminary MR imaging contrast
properties test conducted showed enhanced T1 and T2 signals in the samples
containing the nanocomposites.
Based on the highlighted results, TDS could serve as potential replacement
for the incumbent toxic anticancer agents, which could be used simultaneously
in diagnosis. |
|---|